MedTrace Logo

Prochlorperazine vs Imitrex for Acute Migraine in the Emergency Department

NCT00573599 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-08-19

No results posted yet for this study

Summary

ED patients with acute migraine will be randomized to either prochlorperazine and Bendaryl OR imitrex. VAS for pain will be monitored, along with side effects. Primary outcome measure is improvement in pain scales between the groups.

Conditions

  • Acute Migraine Headache

Interventions

DRUG

prochlorperazine and benadryl IV

prochlorperazine and benadryl IV, saline subQ

DRUG

Imitrex SubQ, saline IV

Imitrex SubQ, saline IV

Sponsors & Collaborators

  • United States Naval Medical Center, Portsmouth

    lead FED

Principal Investigators

  • Frank Gutierrez, MD · US Navy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2007-05-31
Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00573599 on ClinicalTrials.gov